According to a recent pharmacological report:
“Cepharanthine is a fascinating pharmacological agent with a complex set of physiological actions and an array of clinical benefits. To date, preclinical and clinical studies have provided compelling evidence for the potential uses of Cepharanthine in… idiopathic thrombocytopenic purpura.”
Clinical trials have shown that many ITP patients who were on a daily regimen of Cepharanthine had a significant elevation in platelet counts without any reported side effects.
Incredibly, a number of these patients were still experiencing elevated platelet counts up to 5 months after stopping Cepharanthine treatment.
Research has shown no difference in the results between patients who were treated with Cepharanthine alone and those who were treated with Cepharanthine in combination with Prednisolone (a man-made corticosteroid). As a result of Cepharanthine, many patients were able to either reduce or completely wean themselves off steroids.
In two studies involving pediatric ITP, children who were being administered Cepharanthine had their platelet levels fully restored to normal, even quicker than the standard costly platelet associated IgG treatment.